Sinclair Pharma (XPAR:SPH) Total Stockholders Equity : €101.08 Mil (As of Jun. 2018)

View and export this data going back to . Start your Free Trial

What is Sinclair Pharma Total Stockholders Equity?

Sinclair Pharma's Total Stockholders Equity for the quarter that ended in Jun. 2018 was €101.08 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Sinclair Pharma's Book Value per Share for the quarter that ended in Jun. 2018 was €0.24. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Sinclair Pharma's Debt-to-Equity for the quarter that ended in Jun. 2018 was 0.20.

Sinclair Pharma Total Stockholders Equity Historical Data

The historical data trend for Sinclair Pharma's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinclair Pharma Total Stockholders Equity Chart

Sinclair Pharma Annual Data

Trend

Jun07

Jun08

Jun09

Jun10

Jun11

Jun12

Jun13

Jun14

Jun15

Dec17

Total Stockholders Equity

Get a 7-Day Free Trial

141.65

129.91

146.85

146.52

112.35

Sinclair Pharma Semi-Annual Data
	Jun08	Dec08	Jun09	Dec09	Jun10	Dec10	Jun11	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Jun17	Dec17	Jun18
Total Stockholders Equity	Get a 7-Day Free Trial															143.77	139.35	105.84	112.35	101.08

Sinclair Pharma (XPAR:SPH) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Sinclair Pharma's Book Value per Share for the quarter that ended in Jun. 2018 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(101.083	-	0)	/	419.059
	=	0.24

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Sinclair Pharma's Debt-to-Equity for the quarter that ended in Jun. 2018 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	20.677)	/	101.083
	=	0.20

Sinclair Pharma Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Sinclair Pharma's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinclair Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sinclair Pharma PLC (XPAR:SPH) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.sinclairispharma.com

Sinclair Pharma PLC is a United Kingdom-based specialty pharmaceutical company focused on Dermatology, in particular, Aesthetics, Wound care, and Skin care. The group has a direct sales and marketing presence in the top five European markets and a rapidly growing International division concentrated on key emerging markets through long-term multi-product, multi-country, sales & marketing and distribution deals with key strategic partners. The Company's reportable operating segments are International Operations, France, Italy, Germany, UK, and Spain.